Invitae Corporation (NVTA): Price and Financial Metrics

Invitae Corporation (NVTA): $3.07

0.26 (+9.25%)

POWR Rating

Component Grades














  • Growth is the dimension where NVTA ranks best; there it ranks ahead of 39.98% of US stocks.
  • The strongest trend for NVTA is in Quality, which has been heading down over the past 179 days.
  • NVTA's current lowest rank is in the Quality metric (where it is better than 7.45% of US stocks).

NVTA Stock Summary

  • With a year-over-year growth in debt of 283.02%, Invitae Corp's debt growth rate surpasses 95.79% of about US stocks.
  • The volatility of Invitae Corp's share price is greater than that of 94.31% US stocks with at least 200 days of trading history.
  • Invitae Corp's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -77.81%, greater than the shareholder yield of only 5.24% of stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Invitae Corp are PROF, IMCR, SRNE, QLGN, and POWI.
  • NVTA's SEC filings can be seen here. And to visit Invitae Corp's official web site, go to

NVTA Valuation Summary

  • In comparison to the median Healthcare stock, NVTA's EV/EBIT ratio is 159.39% lower, now standing at -17.4.
  • NVTA's price/sales ratio has moved down 3416.5 over the prior 80 months.
  • Over the past 80 months, NVTA's price/earnings ratio has gone down 0.3.

Below are key valuation metrics over time for NVTA.

Stock Date P/S P/B P/E EV/EBIT
NVTA 2021-08-31 16.6 2.4 -20.6 -17.4
NVTA 2021-08-30 16.3 2.4 -20.2 -17.1
NVTA 2021-08-27 16.1 2.4 -20.1 -17.0
NVTA 2021-08-26 15.5 2.3 -19.3 -16.3
NVTA 2021-08-25 15.6 2.3 -19.3 -16.4
NVTA 2021-08-24 15.4 2.3 -19.2 -16.3

NVTA Growth Metrics

    Its year over year net income to common stockholders growth rate is now at -102.48%.
  • Its year over year price growth rate is now at 76.47%.
  • Its 2 year net cashflow from operations growth rate is now at -64.49%.
NVTA's revenue has moved up $449,345,000 over the prior 70 months.

The table below shows NVTA's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 460.449 -559.815 -379.006
2021-09-30 434.759 -497.479 -408.22
2021-06-30 389.092 -394.593 -312.946
2021-03-31 318.971 -325.662 -613.135
2020-12-31 279.598 -298.502 -602.17
2020-09-30 245.452 -232.186 -444.737

NVTA's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • NVTA has a Quality Grade of D, ranking ahead of 13.88% of graded US stocks.
  • NVTA's asset turnover comes in at 0.118 -- ranking 73rd of 81 Healthcare stocks.
  • BKD, VCYT, and HCSG are the stocks whose asset turnover ratios are most correlated with NVTA.

The table below shows NVTA's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.118 0.281 -0.331
2021-03-31 0.139 0.268 -0.887
2020-12-31 0.183 0.291 -1.070
2020-09-30 0.284 0.321 -0.721
2020-06-30 0.280 0.347 -0.790
2020-03-31 0.336 0.429 -0.705

NVTA Stock Price Chart Interactive Chart >

Price chart for NVTA

NVTA Price/Volume Stats

Current price $3.07 52-week high $35.51
Prev. close $2.81 52-week low $2.08
Day low $2.88 Volume 29,124,900
Day high $3.35 Avg. volume 7,593,453
50-day MA $4.04 Dividend yield N/A
200-day MA $13.79 Market Cap 703.92M

Invitae Corporation (NVTA) Company Bio

Invitae Corporation is a company that utilizes an integrated portfolio of laboratory processes, software tools and informatics capabilities to process deoxyribonucleic acid (DNA)-containing samples, analyze information about patient-specific genetic variation and generate test reports for physicians and their patients. The company was founded in 2012 and is based in San Francisco, California.

NVTA Latest News Stream

Event/Time News Detail
Loading, please wait...

NVTA Latest Social Stream

Loading social stream, please wait...

View Full NVTA Social Stream

Latest NVTA News From Around the Web

Below are the latest news stories about Invitae Corp that investors may wish to consider to help them evaluate NVTA as an investment opportunity.

Invitae's (NVTA) CEO Sean George on Q4 2021 Results - Earnings Call Transcript

Invitae Corporation (NVTA) Q4 2021 Earnings Conference Call February 24, 2022 4:30 PM ET Company Participants Jack Finks – Investor Relations Sean George – Chief Executive Officer Roxi Wen – Chief Financial Officer Ken Knight – Chief Operating Officer Conference Call Participants Dan Brennan – Cowen Chad Wiatrowski – SVB...

SA Transcripts on Seeking Alpha | February 25, 2022

Invitae Reports $460.4 Million in Annual Revenue Driven by 1.17 Million in Billable Volume in 2021

Invitae (NYSE: NVTA), a leading medical genetics company, today announced financial and operating results for the fourth quarter and year ended December 31, 2021.

Yahoo | February 24, 2022

This Week's 5 Must-See Earnings Charts

Will earnings matter for these 5 trending stocks?

Yahoo | February 24, 2022

Cathie Wood is Doubling Down on These 10 Stocks Despite Losses

In this article, we discuss the 10 stocks that Cathie Wood is doubling down on despite losses. If you want to skip our detailed analysis of these stocks, go directly to Cathie Wood is Doubling Down on These 5 Stocks Despite Losses. The prospect of rising interest rates has pushed investors to sell risky offerings […]

Yahoo | February 23, 2022

10 Genomics Stocks in Cathie Wood’s Portfolio That Are Underperforming

In this article, we discuss 10 genomics stocks in Cathie Wood’s portfolio that are underperforming. If you want to skip our detailed analysis of these stocks, go directly to 5 Genomics Stocks in Cathie Wood’s Portfolio That Are Underperforming. ARK Investment Management is an innovation-focused hedge fund that is headquartered in St. Petersburg, Florida, with […]

Yahoo | February 23, 2022

Read More 'NVTA' Stories Here

NVTA Price Returns

1-mo -23.63%
3-mo -65.27%
6-mo -79.12%
1-year -91.09%
3-year -86.94%
5-year -68.12%
YTD -79.90%
2021 -63.48%
2020 159.21%
2019 45.84%
2018 21.81%
2017 14.36%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.6359 seconds.